|
Index of reports
> Cases with Platelet Count Decreased (77)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include platelet count decreased. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 77 Next >>
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Platelet Count Decreased
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-02-07
Peginterferon Alfa-2B
Dosage: 1.0 ?g/kg, qw
Start date: 2012-02-15
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-01-31
End date: 2012-02-08
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-15
End date: 2012-07-11
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-09
End date: 2012-02-14
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-04-24
Other drugs received by patient: Ferotym; Epadel S; Etizolam; Norvasc; Depas; Claritin Reditabs; Livalo
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram, qw
Start date: 2012-05-02
End date: 2012-05-02
PEG-Intron
Dosage: 40 microgram, qw
Start date: 2012-06-06
End date: 2012-06-20
PEG-Intron
Dosage: 50 microgram, qw
Start date: 2012-04-18
End date: 2012-04-18
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-04-11
PEG-Intron
Dosage: 30 microgram,
Start date: 2012-06-27
End date: 2012-06-27
PEG-Intron
Dosage: 75 microgram, qw
Start date: 2012-04-25
End date: 2012-04-25
PEG-Intron
Dosage: 50 microgram, qw
Start date: 2012-05-09
End date: 2012-05-30
PEG-Intron
Dosage: 40 microgram, unk
Start date: 2012-07-04
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
Telavic
Dosage: 1.5 g, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-04-14
Telavic
Dosage: 1.5 g, qd
Administration route: Oral
End date: 2012-06-27
Telavic
Dosage: unk
Administration route: Oral
Start date: 2012-04-17
Other drugs received by patient: Glycyron; Talion (Bepotastine Besylate); Loxonin; Loxonin; Urso 250; NEO-Minophagen C; Motilium
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 mcg /kg/week
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-04-25
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-06-26
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-04-26
End date: 2012-06-06
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-06
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-07
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-06-26
End date: 2012-07-24
Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Platelet Count Decreased
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.1 ?g/kg, qw
Start date: 2012-04-06
End date: 2012-04-19
Peginterferon Alfa-2B
Dosage: 1.4 ?g/kg, unknown
Start date: 2012-04-20
Peginterferon Alfa-2B
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-02-03
Peginterferon Alfa-2B
Dosage: 1.4 ?g/kg, qw
End date: 2012-04-05
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-03
End date: 2012-07-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-03
End date: 2012-04-26
Other drugs received by patient: Loxonin; Diclofenac Sodium
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Haemoglobin Decreased, Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.3 microgram per kilogram, qw
Start date: 2012-06-01
PEG-Intron
Dosage: 1.7 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-25
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-29
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-17
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-01
End date: 2012-06-07
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-22
End date: 2012-06-28
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-18
End date: 2012-05-31
Telavic
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-06-01
End date: 2012-06-07
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-31
Telavic
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-06-22
End date: 2012-07-18
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Pneumonia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram
Start date: 2012-03-06
End date: 2012-03-13
PEG-Intron
Dosage: 0.75 microgram per kilogram, qw
Start date: 2012-05-15
PEG-Intron
Dosage: 0.75 microgram per kilogram, qw
Start date: 2012-03-20
End date: 2012-05-01
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2012-05-15
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-06
End date: 2012-05-07
Telaprevir
Dosage: 2250 mg, qd
Administration route: Oral
Start date: 2012-05-15
End date: 2012-06-05
Telaprevir
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-06
End date: 2012-05-07
Other drugs received by patient: Betamethasone Sodium Phosphate; [therapy Unspecified]; Allegra; Allopurinol; Rabeprazole Sodium; Atarax; Meropenem
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Platelet Count Decreased
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.18 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-02-06
End date: 2012-02-15
Peginterferon Alfa-2B
Dosage: 0.5 ?g/kg, qw
Start date: 2012-04-06
End date: 2012-07-23
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-04-06
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-12
End date: 2012-07-23
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-06
End date: 2012-02-15
Telavic
Dosage: 500 mg, qd
Administration route: Oral
Start date: 2012-04-06
End date: 2012-05-31
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-06
End date: 2012-02-15
Other drugs received by patient: Voltaren; Mefenamic Acid; Selbex; Voltaren-XR
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-23
Patient:
Reactions: Anaemia, Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-06
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-25
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-26
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
Other drugs received by patient: Ferotym; Claritin Reditabs; Livalo; Epadel S
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-23
Patient:
Reactions: Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-30
End date: 2012-06-06
PEG-Intron
Dosage: 1.5 microgram, per week
Start date: 2012-06-13
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2012-06-13
End date: 2012-06-27
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-07-04
End date: 2012-07-11
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-30
End date: 2012-06-06
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-07-11
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-06-27
End date: 2012-07-04
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-30
End date: 2012-06-06
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-06-13
Other drugs received by patient: Allopurinol; Urso 250; Loxonin; Mucosta
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Haemoglobin Decreased, Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-25
End date: 2012-05-31
PEG-Intron
Dosage: 0.75 microgram per kilogram, qw
Start date: 2012-06-01
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-06-22
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-25
End date: 2012-06-21
Rebetol
Dosage: unk
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-25
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-22
Patient:
Reactions: Confusional State, Affect Lability, Completed Suicide, Platelet Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram, qw
Start date: 2012-05-29
End date: 2012-06-05
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2012-05-23
End date: 2012-05-23
Rebetol
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-23
End date: 2012-06-01
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Hepatic Encephalopathy, Dehydration, Hyperammonaemia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.23mcg/kg/week
Start date: 2012-03-24
PEG-Intron
Dosage: 1.48mcg/kg/week
Indication: Hepatitis C
Start date: 2012-01-21
End date: 2012-02-17
PEG-Intron
Dosage: 1.10mcg/kg/week
Start date: 2012-03-03
End date: 2012-03-23
PEG-Intron
Dosage: 1.38mcg/kg/week
Start date: 2012-02-18
End date: 2012-03-02
Rebetol
Administration route: Oral
Start date: 2012-03-11
End date: 2012-04-14
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-21
End date: 2012-02-03
Rebetol
Administration route: Oral
Start date: 2012-04-15
End date: 2012-05-12
Rebetol
Administration route: Oral
Start date: 2012-05-13
Rebetol
Administration route: Oral
Start date: 2012-02-04
End date: 2012-03-10
Telavic
Administration route: Oral
Start date: 2012-03-01
End date: 2012-04-14
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-21
End date: 2012-02-29
Other drugs received by patient: Nexium; Xyzal
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-15
Patient:
Reactions: Nausea, Anaemia, Platelet Count Decreased, Hyperuricaemia, Decreased Appetite
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-03-09
End date: 2012-03-29
Peginterferon Alfa-2B
Dosage: 1.2 ?g/kg, qw
Start date: 2012-03-30
End date: 2012-05-03
Peginterferon Alfa-2B
Dosage: 0.9 ?g/kg, qw
Start date: 2012-05-04
End date: 2012-05-10
Peginterferon Alfa-2B
Dosage: 1.2 ?g/kg, qw
Start date: 2012-05-11
End date: 2012-06-01
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-23
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
End date: 2012-06-01
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-03-19
End date: 2012-03-22
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-09
End date: 2012-03-18
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-03-16
End date: 2012-05-17
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-09
End date: 2012-03-15
Telavic
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-05-18
End date: 2012-06-01
Other drugs received by patient: Urso 250; Allopurinol; Caduet; Novamine 15%
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-15
Patient:
Reactions: Anaemia, Platelet Count Decreased
Drug(s) suspected as cause:
Incivek
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-05
PEG-Intron
Dosage: 1.0 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-05
End date: 2012-06-18
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-25
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-05
End date: 2012-06-24
Other drugs received by patient: Ferotym; Epadel S; Claritin Reditabs; Rabeprazole Sodium; Maglax (Magnesium Oxide); PEG-Intron; PEG-Intron
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-14
Patient:
Reactions: Haemoglobin Decreased, Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.2mcg/kg/week
Start date: 2012-06-04
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-20
PEG-Intron
Dosage: 1.3mcg/kg/week
Start date: 2012-02-27
End date: 2012-02-27
PEG-Intron
Dosage: 0.9mcg/kg/week
Start date: 2012-04-09
End date: 2012-05-28
PEG-Intron
Dosage: 0.9mcg/kg/week
Start date: 2012-03-05
End date: 2012-03-05
PEG-Intron
Dosage: 1.3mcg/kg/week
Start date: 2012-03-12
End date: 2012-04-02
Rebetol
Administration route: Oral
Start date: 2012-07-09
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-19
Rebetol
Administration route: Oral
Start date: 2012-03-05
End date: 2012-04-08
Rebetol
Administration route: Oral
Start date: 2012-04-09
End date: 2012-04-22
Rebetol
Administration route: Oral
Start date: 2012-06-18
End date: 2012-07-08
Rebetol
Administration route: Oral
Start date: 2012-02-20
End date: 2012-03-04
Rebetol
Administration route: Oral
Start date: 2012-04-23
End date: 2012-06-17
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-04-09
Other drugs received by patient: Famotidine
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-14
Patient:
Reactions: Platelet Count Decreased, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.7mcg/kg/week
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-18
PEG-Intron
Dosage: 1.27mcg/kg/week
Start date: 2012-06-25
Rebetol
Administration route: Oral
Start date: 2012-06-25
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-18
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-18
Telavic
Administration route: Oral
Start date: 2012-06-25
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-14
Patient:
Reactions: Haemoglobin Decreased, Anaemia, Platelet Count Decreased
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-09
End date: 2012-04-26
Antiviral (Unspecified)
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-04-27
End date: 2012-05-01
Antiviral (Unspecified)
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-05-25
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-09
End date: 2012-04-20
PEG-Intron
Dosage: 0.75mcg/kg/week
Start date: 2012-06-01
PEG-Intron
Dosage: 0.6mcg/kg/week
Start date: 2012-04-27
End date: 2012-04-27
PEG-Intron
Dosage: 0.6mcg/kg/week
Start date: 2012-05-18
End date: 2012-05-25
Rebetol
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-09
End date: 2012-04-12
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2012-04-13
End date: 2012-04-26
Telavic
Administration route: Oral
Start date: 2012-05-25
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-09
End date: 2012-04-26
Telavic
Administration route: Oral
Start date: 2012-04-27
End date: 2012-05-01
Other drugs received by patient: Miya BM; Taipemin; Allopurinol; Allopurinol; Lanizac; Valsartan and Hydrochlorothiazide; Urso 250; Sodium Ferrous Citrate; Ranitidine Hydrochloride; Valsartan and Hydrochlorothiazide; Bezafibrate; Bezafibrate; Allopurinol; Allopurinol
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-14
Patient:
Reactions: Anxiety, Hypoproteinaemia, Platelet Count Decreased, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Interferon Beta NOS
Dosage: 6 million iu, once
Indication: Hepatitis C
Start date: 2010-05-20
End date: 2010-06-03
Interferon Beta NOS
Dosage: 6 million iu, tiw
Start date: 2010-06-04
End date: 2011-10-07
Rebetol
Dosage: 200mg in morning and 400mg in evening
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-05-20
End date: 2011-10-13
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14
Patient:
Reactions: Contusion, Hypotension, Dizziness, Platelet Count Decreased, Loss of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-17
Rebetol
Dosage: 2 df, bid
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-07-01
Rebetol
Dosage: 1 df, bid
Start date: 2012-07-01
Other drugs received by patient: Nifedipine; Coreg; Temazepam; Oxycodone; Amitriptyline HCL; Fosamax; Lisinopril; Aspirin
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: White Blood Cell Count Decreased, RED Blood Cell Count Decreased, Platelet Count Decreased, Menorrhagia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Rebetol
Administration route: Oral
Victrelis
Administration route: Oral
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-10
Patient:
Reactions: Haemoglobin Decreased, Gout, Platelet Count Decreased, Hyperuricaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.5mcg/kg/week
Start date: 2012-03-30
PEG-Intron
Dosage: 1.0mcg/kg/week
Start date: 2012-03-16
End date: 2012-03-29
PEG-Intron
Dosage: 0.45mcg/kg/week
Start date: 2012-05-11
End date: 2012-05-18
PEG-Intron
Dosage: 1.1mcg/kg/week
Start date: 2012-03-02
End date: 2012-03-15
PEG-Intron
Dosage: 0.45mcg/kg/week
Start date: 2012-03-30
End date: 2012-04-06
PEG-Intron
Dosage: 0.75mcg/kg/week
Start date: 2012-04-20
End date: 2012-05-04
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-02-16
End date: 2012-03-01
PEG-Intron
Dosage: 0.6mcg/kg/week
Start date: 2012-04-13
End date: 2012-04-13
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-16
End date: 2012-03-15
Rebetol
Administration route: Oral
Start date: 2012-05-12
Rebetol
Administration route: Oral
Start date: 2012-03-16
End date: 2012-03-22
Rebetol
Administration route: Oral
Start date: 2012-03-23
End date: 2012-03-30
Rebetol
Administration route: Oral
Start date: 2012-04-06
End date: 2012-05-11
Telavic
Administration route: Oral
Start date: 2012-03-23
End date: 2012-03-30
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-16
End date: 2012-03-22
Telavic
Administration route: Oral
Start date: 2012-04-06
End date: 2012-05-10
Other drugs received by patient: Revolade; Confatanin; Revolade
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Platelet Count Decreased, Ammonia Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-04
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-04
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-02
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Basedow's Disease, Weight Decreased, Pruritus, Diabetes Mellitus, Rectal Haemorrhage, Blood Count Abnormal, Appetite Disorder, RED Blood Cell Count Decreased, Anorectal Discomfort, Oedema Peripheral, White Blood Cell Count Decreased, Faeces Hard, Dysgeusia, Mental Impairment, Diarrhoea, Disease Recurrence, Alopecia, Platelet Count Decreased, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2002-01-04
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2005-04-01
End date: 2006-03-03
Pegasys
Dosage: unk
Start date: 2012-03-22
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2002-01-04
Rebetol
Dosage: 3 df, qd
Start date: 2012-03-22
Rebetol
Dosage: unk
Start date: 2005-04-01
End date: 2006-03-03
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-19
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Back Pain, Arthralgia, Alopecia, Anaemia, Platelet Count Decreased, Cerebrovascular Accident, Eye Disorder
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-01-01
End date: 2012-07-28
Rebetol
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
End date: 2012-07-28
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-29
End date: 2012-07-28
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-10
Patient:
Reactions: Confusional State, Affect Lability, Completed Suicide, Platelet Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Pegintron Powder FOR Injection 100microg
Dosage: 120 unk, qw
Start date: 2012-05-23
End date: 2012-05-23
Pegintron Powder FOR Injection 100microg
Dosage: 80 unk, qw
Start date: 2012-05-29
End date: 2012-06-05
Pegintron Powder FOR Injection 100microg
Dosage: 100 microgram, qw
Start date: 2012-05-01
End date: 2012-06-01
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2012-05-01
End date: 2012-06-01
Rebetol
Dosage: 1000 mg, once
Administration route: Oral
Start date: 2012-05-23
End date: 2012-06-01
Possible Rebetol side effects in
Reported by a pharmacist from United States on 2012-08-10
Patient:
Reactions: Fatigue, Anaemia, Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Rebetol
Dosage: 200 mg, unk
Other drugs received by patient: MK-0521
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-10
Patient:
Reactions: Haemoglobin Decreased, Platelet Count Decreased
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-21
PEG-Intron
Dosage: 30mcg/kg/week
Start date: 2012-04-11
PEG-Intron
Dosage: 0.89mcg/kg/week
End date: 2012-06-05
PEG-Intron
Dosage: 40mcg/kg/week
Start date: 2012-04-25
PEG-Intron
Dosage: 1.33mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-21
PEG-Intron
Dosage: 0mcg/kg/week
Start date: 2012-06-06
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-21
End date: 2012-03-27
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-28
Rebetol
Administration route: Oral
Start date: 2012-03-28
End date: 2012-06-05
Rebetol
Administration route: Oral
Start date: 2012-06-06
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-21
Telavic
Administration route: Oral
Start date: 2012-06-06
Telavic
Administration route: Oral
Start date: 2012-05-30
End date: 2012-06-05
Other drugs received by patient: Gasmotin; Allegra; Antebate; [therapy Unspecified]; Herbs (Unspecified)
Possible Rebetol side effects in
Reported by a individual with unspecified qualification from Japan on 2012-08-10
Patient:
Reactions: Renal Disorder, Amylase Increased, Anaemia, Platelet Count Decreased, Neutrophil Count Decreased, Hyperuricaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-22
End date: 2012-02-24
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-25
PEG-Intron
Dosage: unk microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-02-22
Peginterferon Alfa-2B
Dosage: 0.75 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-02-22
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-02
End date: 2012-04-11
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-22
End date: 2012-03-01
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-04-12
Telavic
Dosage: 1500 mg, once
Administration route: Oral
Start date: 2012-02-25
Telavic
Dosage: 2250 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-22
End date: 2012-02-24
Other drugs received by patient: Olmesartan Medoxomil; Claritin; Olmesartan Medoxomil; Allopurinol; Acetaminophen; Allegra; Celestamine TAB; Berizym (Aspergillus Oryzae Extract (+) Cellulase (+) Lipase (+) Pancr; Aspergillus Oryzae Extract (+) Cellulase (+) Lipase (+) Pancreatin; Myser (Cycloserine)
Possible Rebetol side effects in
Reported by a individual with unspecified qualification from Japan on 2012-08-09
Patient:
Reactions: Haemoglobin Decreased, Platelet Count Decreased, Rash
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-02-14
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-14
End date: 2012-04-10
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-25
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-04-11
End date: 2012-04-24
Telaprevir
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2012-02-14
End date: 2012-04-16
Telaprevir
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-04-17
End date: 2012-05-05
Other drugs received by patient: Glucobay; Pancreaze; Pancreaze; Diltiazem HCL; Magnesium Oxide; Lansoprazole; Aspirin; Famotidine; LAC-B; Isodine; LAC-B; Maalox (Aluminum Hydroxide (+) Magnesium Hydroxide); Lansoprazole; Maalox (Aluminum Hydroxide (+) Magnesium Hydroxide); Levofloxacin; Confatanin; Januvia; Glufast; Magnesium Oxide
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient:
Reactions: White Blood Cell Count Decreased, Pruritus, Impaired Healing, Tooth Abscess, Skin Lesion, Tooth Extraction, Platelet Count Decreased, Memory Impairment
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-04
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-04
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-02
Page 1 Next >>
|
